In this interview, Dr. Samir Shah, Chief Medical Officer at Qure.ai, shares why achieving FDA approval is crucial for their AI solutions and for fostering trust in the technology. Dr. Shah discusses how their FDA-cleared tools are assisting clinicians with diagnosing lung cancer, detecting fractures, and identifying critical abnormalities in medical imaging. Learn about Qure.ai’s commitment to ensuring safety, accuracy, and transparency in AI development—and how these factors are making a tangible difference for patients and providers. Learn more about Qure.ai at https://www.qure.ai/ Find more great health IT content at https://www.healthcareittoday.com/